Emergent BioSolutions Inc.
EBS | NYSE
$6.55
-$0.25 (-3.68%)
At close: Sep 21, 2026, 4:00 PM ET
$6.55
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:18 PM ET
Market Data
Market Cap $350.85M
Enterprise Value $780.06M
Beta 2.34
Average Volume 1M
Shares Outstanding (Diluted) 51.6M
Shares Change YoY -4.8%
Institutional Ownership 83.69%
Exchange NYSE
ISIN US29089Q1058
Price Performance
Price Change 1M 30.7%
Price Change 3M -18.2%
Price Change 6M -20.2%
Price Change YTD -47.6%
Price Change 1Y -19.9%
Price Change 3Y 100.9%
Price Change 5Y -87.5%
1M CAGR (ann.) 28.1%
1Y CAGR (ann.) -12.7%
5Y CAGR (ann.) -34.7%
All-Time CAGR -2.7%
Valuation
PE Ratio -1.85
Forward PE 6.54
PEG Ratio -0.10
Forward PEG -0.01
PS Ratio 0.44
Forward PS 0.50
PB Ratio 0.99
P/FCF Ratio 24.85
P/Adj. FCF Ratio -63.77
P/OCF Ratio 3.47
EV/Sales 1.01
EV/EBIT -8.20
EV/EBITDA -32.91
EV/FCF 57.36
Earnings Yield -54.2%
FCF Yield 4.0%
Adj. FCF Yield -1.6%
Financial Health
Net Debt $442.1M
Total Debt $581.8M
Cash & Short-Term Investments $139.7M
Total Assets $1.12B
Current Ratio 5.42
Quick Ratio 2.95
Debt / Equity Ratio 1.70
Debt / EBITDA -24.55
Debt / FCF 42.78
OCF / Debt 0.04
Interest Coverage -1.07
Altman Z-Score 0.85
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 49.4%
Operating Profit Margin -7.1%
EBITDA Margin -3.1%
Net Profit Margin -23.0%
FCF Margin 1.8%
Adj. FCF Margin -0.7%
SBC / Revenue 2.5%
SBC Impact (per share) -139.0%
Returns
Return on Assets -15.8%
Return on Equity -35.9%
Return on Invested Capital -5.5%
Return on Capital Employed -5.5%
Return on Tangible Assets -20.7%
Historical Growth (CAGR)
Revenue CAGR 3Y -10.4%
Revenue CAGR 5Y -14.7%
Revenue CAGR 10Y 4.2%
EPS CAGR 3Y 93.6%
EPS CAGR 5Y 8.9%
EPS CAGR 10Y -83.8%
FCF CAGR 3Y -17.5%
FCF CAGR 5Y -35.4%
FCF CAGR 10Y -16.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y 42.0%
Revenue Growth Next 3Y 7.7%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.37
EPS Growth Est (next Q) -134.9%
Revenue Est (next Q) $123.22M
Revenue Growth Est (next Q) -46.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $10
Price Target Upside 52.7%
Cash Flow
Operating Cash Flow $25.4M
Free Cash Flow $13.6M
Adj. Free Cash Flow $-5.3M
FCF Per Share $1.66
OCF Per Share $1.89
OCF/S Ratio 12.7%
Income Statement
Revenue $770.2M
Gross Profit $380.5M
Operating Income $-54.4M
EBITDA $-23.7M
Net Income $-176.8M
EPS (Diluted) -$3.55
Revenue / Employee $855.78K
Profit / Employee $-196.44K
Employees 900
Add to Watchlist
Select watchlists to add or remove EBS